Clinical Trials Browser

Phase EARLY_PHASE1 × Myelodysplastic Syndromes × 1 year × Clear all

Myelodysplastic Syndromes, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic

NCT06765876 2026-01-12

UHKT-CAR123-01

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04628338 2025-04-29

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Phase EARLY_PHASE1 Completed

8 enrolled

MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04187703 2025-04-09

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Phase EARLY_PHASE1 Recruiting

20 enrolled

Myeloid

Myelodysplastic Syndromes

Clinical Trials

M-HArbOr

UHKT-CAR123-01

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies